Teleflex Incorporated (TFX)
NYSE · Healthcare · Medical Instruments & Supplies
$125.24+0.90%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $5.3B
- Forward P/E
- 11.4
- Dividend yield
- 1.1%
- 52-week range
- $100.18 – $145.00
- 52-week change
- −2.18%
- EPS (trailing)
- −$8.48
- Analyst rating
- 2.4 Buy
- Next earnings
- Oct 29, 2026
Fiscal year to Dec 2025
- Revenue
- $2.0B (+17.25%)
- Net income
- −$906M
- Operating margin
- 5.9%
- Diluted EPS
- −$20.25
From the company’s annual report on SEC EDGAR.
About Teleflex Incorporated
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand.
Headquarters: Wayne, United States · 15,500 employees · teleflex.com